Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05107908 · ClinicalTrials.gov registry record · NA
Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity
A NA study of Overweight and Obesity, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 228
- Enrollment target
- 1
- Study location
NCT05107908: Recruiting NA study of Overweight and Obesity, sponsored by University of Colorado, Denver.
NCT05107908 is a NA study of Overweight and Obesity that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 228 participants, roughly in line with the 226-participant average among 115 other Overweight and Obesity trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05107908, a NA study of Overweight and Obesity, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 228 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine how different behavioral interventions designed to alter food perceptions and behaviors affect brain responses to food, eating behaviors, and body weight.
Primary Outcome
Percent change in blood oxygen level dependent (BOLD) response from baseline to after the 12-week intervention while viewing visual food cues will be measured using functional magnetic resonance imaging (fMRI), focusing on insula, striatum, and prefrontal cortex.
Conditions Studied
Interventions
- BEHAVIORAL Active Implicit Priming
- BEHAVIORAL Control Implicit Priming
- BEHAVIORAL Food Exposure Task
Study Locations (1)
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 228 participants |
| Start Date | 2021-11-12 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT05107908 shows while recruiting
NCT05107908 is an interventional study that assigns participants to a tested intervention. The registered 228 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 226-participant average among 115 other Overweight and Obesity trials with a reported enrollment target.
The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 3 interventions - of which Active Implicit Priming is the first listed.
NCT05107908 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT05107908 about?
NCT05107908 is a clinical study titled "Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity". The purpose of this study is to determine how different behavioral interventions designed to alter food perceptions and behaviors affect brain responses to food, eating behaviors, and body weight.
What is the current status of trial NCT05107908?
This trial is currently recruiting. It is a NA study. The enrollment target is 228 participants. The study started on 2021-11-12. Estimated completion is 2026-08.
What conditions does trial NCT05107908 study?
This clinical trial studies the following conditions: Overweight and Obesity.
What interventions are being tested in trial NCT05107908?
The interventions under investigation include: Active Implicit Priming (BEHAVIORAL), Control Implicit Priming (BEHAVIORAL), Food Exposure Task (BEHAVIORAL).
Who is sponsoring clinical trial NCT05107908?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05107908 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight and Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05107908's enrollment target sits among peer trials
228 30th of 115 higher than 86 of 115 other Overweight and Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dose Response Effects of Pecan Consumption
RECRUITING · NA
-
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
RECRUITING · NA
-
Cottonseed Oil Dose Response
RECRUITING · NA
-
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
RECRUITING · NA
-
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
RECRUITING · NA
-
Cottonseed Oil Versus Matched PUFA Effects
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05547698 · 228 participants · NA
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
- NCT05630963 · 228 participants
Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression
- NCT06073665 · 228 participants · Phase 4
Dosing of LT4 in Older Individuals
- NCT06116422 · 228 participants · NA
Nutrition and Obesity in Under-Represented Populations: Food Insecurity Research to Advance Science and Improve Health
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI